Investing Profile

Charles Homcy

InvestorVC

Partner at Third Rock Ventures

thirdrockventures.com/people/...San Francisco, California
Photo of Charles Homcy, Partner at Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
4
$770M
CompanyStageDateRound SizeTotal Raised
Maze Therapeutics
Series AFeb 2019$190M
$190M
Co-investors: Jonathan Lim (SignalFire), Jonathan Lim (ARCH Venture Partners)
CytomX Therapeutics
Series CJan 2015$20M
$20M
Co-investors: Tim Shannon (Canaan Partners), Neil Exter (Third Rock Ventures)
MyoKardia
Venture RoundAug 2014$10M
$10M
Topica Pharmaceuticals
Series BOct 2011$27M
$27M